{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:12:27Z","timestamp":1791141147649,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A comprehensive understanding of the underlying molecular mechanisms of prostate cancer is essential for the development of precise diagnostic biomarkers. In this study, we applied the unsupervised multi-omics factor analysis framework (MOFA) to integrate DNA methylation, gene expression, and metabolic profiles derived from the same individuals, aiming to characterize the biological landscape of normal, malignant, and aggressive prostate tissue. Our analysis identified distinct molecular pathways associated with aggressive disease, specifically those involved in zinc metabolism, cell cycle regulation, smooth muscle architecture, immune activation, and tissue morphology. Key metabolites within the TCA cycle, amino acid metabolism, and lipid pathways were central to these signatures. Furthermore, we observed a consistent co-enrichment of SP1 and CTCFL binding regions among factor-associated CpGs, suggesting a model of global epigenetic reprogramming. These findings indicate a novel interplay between Polycomb deregulation, CTCFL-mediated chromatin remodeling, and SP1-driven transcriptional activation in shaping the prostate cancer epigenome. Apart from immune activation, the identified molecular signatures were validated in the TCGA cohort and demonstrated significant predictive value for disease recurrence. Overall, these results underscore the power of multi-omics integration in providing a holistic understanding of prostate cancer biology and its potential for clinical translation into prognostic biomarkers.<\/jats:p>","DOI":"10.1186\/s12885-026-16232-7","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T07:58:08Z","timestamp":1780905488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated multi-omics profiling uncovers the epigenetic, transcriptional, and metabolic landscape of prostate cancer progression"],"prefix":"10.1186","volume":"26","author":[{"given":"Christine Aaser\u00f8d","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Wess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Midtbust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhibhav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Beck","family":"Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May-Britt","family":"Tessem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"16232_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12916-015-0405-5","volume":"13","author":"T Lloyd","year":"2015","unstructured":"Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008\u20132010. BMC Med. 2015;13:171.","journal-title":"BMC Med"},{"issue":"6","key":"16232_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and Prevention of Prostate Cancer. Eur Urol Oncol. 2021;4(6):877\u201392.","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"16232_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12943-023-01863-2","volume":"22","author":"S Figiel","year":"2023","unstructured":"Figiel S, Yin W, Doultsinos D, Erickson A, Poulose N, Singh R, et al. Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures. Mol Cancer. 2023;22(1):162.","journal-title":"Mol Cancer"},{"issue":"1\u20132","key":"16232_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000477852","volume":"85","author":"Y Tolkach","year":"2018","unstructured":"Tolkach Y, Kristiansen G. The Heterogeneity of Prostate Cancer: A Practical Approach. Pathobiology. 2018;85(1\u20132):108\u201316.","journal-title":"Pathobiology"},{"key":"16232_CR5","doi-asserted-by":"publisher","first-page":"117793221989905","DOI":"10.1177\/1177932219899051","volume":"14","author":"I Subramanian","year":"2020","unstructured":"Subramanian I, Verma S, Kumar S, Jere A, Anamika K. Multi-omics Data Integration, Interpretation, and Its Application. Bioinform Biol Insights. 2020;14:1177932219899051.","journal-title":"Bioinform Biol Insights"},{"issue":"1","key":"16232_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13059-020-02015-1","volume":"21","author":"R Argelaguet","year":"2020","unstructured":"Argelaguet R, Arnol D, Bredikhin D, Deloro Y, Velten B, Marioni JC, et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 2020;21(1):111.","journal-title":"Genome Biol"},{"key":"16232_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nrm3789","volume":"15","author":"PA Steffen","year":"2014","unstructured":"Steffen PA, Ringrose L. What are memories made of? How Polycomb and Trithorax proteins mediate epigenetic memory. Nat Rev Mol Cell Biol. 2014;15:340.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6907","key":"16232_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419(6907):624\u20139.","journal-title":"Nature"},{"key":"16232_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.04.009","volume":"166","author":"CE Massie","year":"2017","unstructured":"Massie CE, Mills IG, Lynch AG. The importance of DNA methylation in prostate cancer development. J Steroid Biochem Mol Biol. 2017;166:1\u201315.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"16232_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/pros.21260","volume":"71","author":"H Bertilsson","year":"2011","unstructured":"Bertilsson H, Angelsen A, Viset T, Skogseth H, Tessem M-B, Halgunset J. A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy. Prostate. 2011;71(5):461\u20139.","journal-title":"Prostate"},{"key":"16232_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2105-10-83","volume":"10","author":"T Wang","year":"2009","unstructured":"Wang T, Shao K, Chu Q, Ren Y, Mu Y, Qu L, et al. Automics: an integrated platform for NMR-based metabonomics spectral processing and data analysis. BMC Bioinformatics. 2009;10:83.","journal-title":"BMC Bioinformatics"},{"key":"16232_CR12","unstructured":"Eilers P, Boelens H. Baseline Correction with Asymmetric Least Squares Smoothing. Unpubl Manuscr. 2005."},{"issue":"2","key":"16232_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jmr.2009.11.012","volume":"202","author":"F Savorani","year":"2010","unstructured":"Savorani F, Tomasi G, Engelsen SB. icoshift: A versatile tool for the rapid alignment of 1D NMR spectra. J Magn Reson. 2010;202(2):190\u2013202.","journal-title":"J Magn Reson"},{"issue":"4","key":"16232_CR14","doi-asserted-by":"publisher","first-page":"e62375","DOI":"10.1371\/journal.pone.0062375","volume":"8","author":"GF Giske\u00f8deg\u00e5rd","year":"2013","unstructured":"Giske\u00f8deg\u00e5rd GF, Bertilsson H, Seln\u00e6s KM, Wright AJ, Bathen TF, Viset T, et al. Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness. PLoS ONE. 2013;8(4):e62375.","journal-title":"PLoS ONE"},{"issue":"27","key":"16232_CR15","doi-asserted-by":"publisher","first-page":"42071","DOI":"10.18632\/oncotarget.9817","volume":"7","author":"AF Hansen","year":"2016","unstructured":"Hansen AF, Sandsmark E, Rye MB, Wright AJ, Bertilsson H, Richardsen E, et al. Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer. Oncotarget. 2016;7(27):42071\u201385.","journal-title":"Oncotarget"},{"issue":"11","key":"16232_CR16","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/bjc.2017.346","volume":"117","author":"PR Braadland","year":"2017","unstructured":"Braadland PR, Giske\u00f8deg\u00e5rd G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, et al. Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy. Br J Cancer. 2017;117(11):1656\u201364.","journal-title":"Br J Cancer"},{"issue":"7","key":"16232_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013;30(7):923\u201330.","journal-title":"Bioinformatics"},{"key":"16232_CR18","doi-asserted-by":"crossref","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genomics Bioinf. 2020;2(3).","DOI":"10.1093\/nargab\/lqaa078"},{"issue":"4","key":"16232_CR19","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4):e22.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"16232_CR20","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"16232_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics"},{"key":"16232_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"16232_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12864-018-4533-0","volume":"19","author":"Y Xi","year":"2018","unstructured":"Xi Y, Shi J, Li W, Tanaka K, Allton KL, Richardson D, et al. Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes. BMC Genomics. 2018;19(1):150.","journal-title":"BMC Genomics"},{"issue":"D1","key":"16232_CR24","doi-asserted-by":"publisher","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","volume":"48","author":"Y Luo","year":"2020","unstructured":"Luo Y, Hitz BC, Gabdank I, Hilton JA, Kagda MS, Lam B, et al. New developments on the Encyclopedia of DNA Elements (ENCODE) data portal. Nucleic Acids Res. 2020;48(D1):D882\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"16232_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841\u20132.","journal-title":"Bioinformatics"},{"issue":"4","key":"16232_CR26","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/nar\/gky1210","volume":"47","author":"M Gheorghe","year":"2019","unstructured":"Gheorghe M, Sandve GK, Khan A, Ch\u00e8neby J, Ballester B, Mathelier A. A map of direct TF-DNA interactions in the human genome. Nucleic Acids Res. 2019;47(4):e21.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"16232_CR27","doi-asserted-by":"publisher","first-page":"D260","DOI":"10.1093\/nar\/gkx1126","volume":"46","author":"A Khan","year":"2018","unstructured":"Khan A, Fornes O, Stigliani A, Gheorghe M, Castro-Mondragon JA, van der Lee R, et al. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 2018;46(D1):D260\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"16232_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14(1):7.","journal-title":"BMC Bioinformatics"},{"key":"16232_CR29","unstructured":"Biecek AKaMKaP. survminer: Drawing Survival Curves using \u2018ggplot2\u2019. 2025."},{"issue":"1","key":"16232_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3892\/mmr.2015.3459","volume":"12","author":"S Takahashi","year":"2015","unstructured":"Takahashi S. Positive and negative regulators of the metallothionein gene (review). Mol Med Rep. 2015;12(1):795\u20139.","journal-title":"Mol Med Rep"},{"key":"16232_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.abb.2016.04.014","volume":"611","author":"LC Costello","year":"2016","unstructured":"Costello LC, Franklin RB. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch Biochem Biophys. 2016;611:100\u201312.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"16232_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40170-021-00242-z","volume":"9","author":"MK Andersen","year":"2021","unstructured":"Andersen MK, H\u00f8iem TS, Claes BSR, Balluff B, Martin-Lorenzo M, Richardsen E, et al. Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI. Cancer Metabolism. 2021;9(1):9.","journal-title":"Cancer Metabolism"},{"issue":"6","key":"16232_CR33","doi-asserted-by":"publisher","first-page":"104451","DOI":"10.1016\/j.isci.2022.104451","volume":"25","author":"MB Rye","year":"2022","unstructured":"Rye MB, Krossa S, Hall M, van Mourik C, Bathen TF, Drabl\u00f8s F, et al. The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems. iScience. 2022;25(6):104451.","journal-title":"iScience"},{"issue":"10","key":"16232_CR34","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25(10):1010\u201322.","journal-title":"Genes Dev"},{"issue":"2","key":"16232_CR35","first-page":"638","volume":"21","author":"H Huang","year":"2025","unstructured":"Huang H, Zhang W. The SP1\/SNHG16\/GLUT1 axis promotes prostate cancer proliferation and invasion by regulating glucose metabolism. Archives Med Sci. 2025;21(2):638\u201347.","journal-title":"Archives Med Sci"},{"issue":"1","key":"16232_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12935-025-03888-7","volume":"25","author":"M Yang","year":"2025","unstructured":"Yang M, Li LJ, Qiu GP, Liu H, Gao F. Specificity protein 1 initiates epithelial-mesenchymal transition of circulating tumor cells to inhibit metastasis in prostate cancer. Cancer Cell Int. 2025;25(1):255.","journal-title":"Cancer Cell Int"},{"key":"16232_CR37","doi-asserted-by":"crossref","unstructured":"Peng S, Lin W, Li Z, Zhuang R, Peng S, Li B, et al. Cancer cell-intrinsic cholesterol induces lipid-associated macrophage differentiation via SP1 palmitoylation to promote prostate cancer progression. Adv Sci (Weinh). 2026;13(19):e08588.","DOI":"10.1002\/advs.202508588"},{"key":"16232_CR38","doi-asserted-by":"publisher","unstructured":"CheemaZ, Hari\u2010Gupta Y, Kita GX, Farrar D, Seddon I, Corr J, et al. Expression of the cancer\u2010testis antigen BORIS correlates with prostate cancer. The Prostate. 2014;74(2):164\u201376. https:\/\/doi.org\/10.1002\/pros.22738.","DOI":"10.1002\/pros.22738"},{"key":"16232_CR39","doi-asserted-by":"crossref","unstructured":"Klenova EM, Morse HC 3rd, Ohlsson R, Lobanenkov VV. The novel BORIS\u2009+\u2009CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin Cancer Biol. 2002;12(5):399\u2013414.","DOI":"10.1016\/S1044-579X(02)00060-3"},{"issue":"2","key":"16232_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ijc.28025","volume":"133","author":"JL Boormans","year":"2013","unstructured":"Boormans JL, Korsten H, Ziel-van der Made AJC, van Leenders GJLH, de Vos CV, Jenster G, et al. Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer. Int J Cancer. 2013;133(2):335\u201345.","journal-title":"Int J Cancer"},{"issue":"1","key":"16232_CR41","doi-asserted-by":"publisher","first-page":"111669","DOI":"10.1016\/j.yexcr.2019.111669","volume":"385","author":"S Chen","year":"2019","unstructured":"Chen S, Wang J, Wang L, Peng H, Xiao L, Li C, et al. Silencing TTK expression inhibits the proliferation and progression of prostate cancer. Exp Cell Res. 2019;385(1):111669.","journal-title":"Exp Cell Res"},{"issue":"1","key":"16232_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ccr.2005.06.011","volume":"8","author":"BAA Weaver","year":"2005","unstructured":"Weaver BAA, Cleveland DW. Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell. 2005;8(1):7\u201312.","journal-title":"Cancer Cell"},{"issue":"10","key":"16232_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrc1714","volume":"5","author":"GJPL Kops","year":"2005","unstructured":"Kops GJPL, Weaver BAA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005;5(10):773\u201385.","journal-title":"Nat Rev Cancer"},{"key":"16232_CR44","doi-asserted-by":"crossref","unstructured":"Stopsack KH, Whittaker CA, Gerke TA, Loda M, Kantoff PW, Mucci LA et al. Aneuploidy drives lethal progression in prostate cancer. Proceedings of the National Academy of Sciences. 2019;116(23):11390-5.","DOI":"10.1073\/pnas.1902645116"},{"issue":"6","key":"16232_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41585-023-00845-9","volume":"21","author":"M Carceles-Cordon","year":"2024","unstructured":"Carceles-Cordon M, Orme JJ, Domingo-Domenech J, Rodriguez-Bravo V. The yin and yang of chromosomal instability in prostate cancer. Nat Reviews Urol. 2024;21(6):357\u201372.","journal-title":"Nat Reviews Urol"},{"issue":"6084","key":"16232_CR46","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.1218595","volume":"336","author":"M Jain","year":"2012","unstructured":"Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL, et al. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation. Science. 2012;336(6084):1040\u20134.","journal-title":"Science"},{"issue":"42","key":"16232_CR47","doi-asserted-by":"publisher","first-page":"6556","DOI":"10.1038\/s41388-020-01456-z","volume":"39","author":"S Wen","year":"2020","unstructured":"Wen S, He Y, Wang L, Zhang J, Quan C, Niu Y, et al. Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer. Oncogene. 2020;39(42):6556\u201371.","journal-title":"Oncogene"},{"issue":"18","key":"16232_CR48","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.clinbiochem.2012.08.012","volume":"45","author":"HM Awwad","year":"2012","unstructured":"Awwad HM, Geisel J, Obeid R. The role of choline in prostate cancer. Clin Biochem. 2012;45(18):1548\u201353.","journal-title":"Clin Biochem"},{"issue":"10","key":"16232_CR49","doi-asserted-by":"publisher","first-page":"e4112","DOI":"10.1002\/nbm.4112","volume":"32","author":"K Sonkar","year":"2019","unstructured":"Sonkar K, Ayyappan V, Tressler CM, Adelaja O, Cai R, Cheng M, et al. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. NMR Biomed. 2019;32(10):e4112.","journal-title":"NMR Biomed"},{"issue":"6","key":"16232_CR50","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/nbm.1738","volume":"24","author":"KR Keshari","year":"2011","unstructured":"Keshari KR, Tsachres H, Iman R, Delos Santos L, Tabatabai ZL, Shinohara K, et al. Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed. 2011;24(6):691\u20139.","journal-title":"NMR Biomed"},{"issue":"4","key":"16232_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/genes15040450","volume":"15","author":"KCS Silva","year":"2024","unstructured":"Silva KCS, Tambwe N, Mahfouz DH, Wium M, Cacciatore S, Paccez JD, et al. Transcription Factors in Prostate Cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches. Genes. 2024;15(4):450.","journal-title":"Genes"},{"issue":"1","key":"16232_CR52","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41467-023-37544-3","volume":"14","author":"Z Wei","year":"2023","unstructured":"Wei Z, Wang S, Xu Y, Wang W, Soares F, Ahmed M, et al. MYC reshapes CTCF-mediated chromatin architecture in prostate cancer. Nat Commun. 2023;14(1):1787.","journal-title":"Nat Commun"},{"key":"16232_CR53","doi-asserted-by":"crossref","unstructured":"Zhu H, Lin Q, Gao X, Huang X. Identification of the hub genes associated with prostate cancer tumorigenesis. Front Oncol. 2023;13:1168772.","DOI":"10.3389\/fonc.2023.1168772"},{"issue":"1","key":"16232_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/path.4217","volume":"231","author":"G Ayala","year":"2013","unstructured":"Ayala G, Morello M, Frolov A, You S, Li R, Rosati F, et al. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. J Pathol. 2013;231(1):77\u201387.","journal-title":"J Pathol"},{"issue":"10","key":"16232_CR55","doi-asserted-by":"publisher","first-page":"e0164016","DOI":"10.1371\/journal.pone.0164016","volume":"11","author":"P Hammarsten","year":"2016","unstructured":"Hammarsten P, Dahl Scherdin T, H\u00e4ggl\u00f6f C, Andersson P, Wikstr\u00f6m P, Stattin P, et al. High caveolin-1 expression in tumor stroma is associated with a favourable outcome in prostate cancer patients managed by watchful waiting. PLoS ONE. 2016;11(10):e0164016.","journal-title":"PLoS ONE"},{"issue":"13","key":"16232_CR56","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.7150\/thno.59816","volume":"11","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Chen W, Fan Z, Chen Z, Liang J, Zeng G, et al. Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancer. Theranostics. 2021;11(13):6592\u2013606.","journal-title":"Theranostics"},{"issue":"9","key":"16232_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s42255-020-0251-4","volume":"2","author":"M Hargreaves","year":"2020","unstructured":"Hargreaves M, Spriet LL. Skeletal muscle energy metabolism during exercise. Nat Metabolism. 2020;2(9):817\u201328.","journal-title":"Nat Metabolism"},{"issue":"1","key":"16232_CR58","first-page":"5616807","volume":"2016","author":"M Bizzarri","year":"2016","unstructured":"Bizzarri M, Dinicola S, Bevilacqua A, Cucina A. Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate. Int J Endocrinol. 2016;2016(1):5616807.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"16232_CR59","doi-asserted-by":"publisher","first-page":"10160","DOI":"10.1038\/s41467-025-65161-9","volume":"16","author":"S Krossa","year":"2025","unstructured":"Krossa S, Andersen MK, Sandholm EM, Wess M, Kiviaho A, Sharma A, et al. Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment. Nat Commun. 2025;16(1):10160.","journal-title":"Nat Commun"},{"issue":"6","key":"16232_CR60","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19(6):326\u201338.","journal-title":"Nat Rev Cancer"},{"key":"16232_CR61","doi-asserted-by":"publisher","first-page":"d447","DOI":"10.2741\/A291","volume":"3","author":"DG Johnson","year":"1998","unstructured":"Johnson DG, Schneider-Broussard R. Role of E2F in cell cycle control and cancer. Front Biosci. 1998;3:d447\u20138.","journal-title":"Front Biosci"},{"issue":"7","key":"16232_CR62","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1158\/1940-6207.CAPR-17-0407","volume":"11","author":"S Safe","year":"2018","unstructured":"Safe S, Abbruzzese J, Abdelrahim M, Hedrick E. Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development. Cancer Prev Res (Phila). 2018;11(7):371\u201382.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"16232_CR63","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cell.2006.02.043","volume":"125","author":"TI Lee","year":"2006","unstructured":"Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006;125(2):301\u201313.","journal-title":"Cell"},{"issue":"1","key":"16232_CR64","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1038\/s41467-019-13329-5","volume":"10","author":"X Tekpli","year":"2019","unstructured":"Tekpli X, Lien T, R\u00f8ssevold AH, Nebdal D, Borgen E, Ohnstad HO, et al. An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. Nat Commun. 2019;10(1):5499.","journal-title":"Nat Commun"},{"issue":"2","key":"16232_CR65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.5751","volume":"255","author":"DB Joseph","year":"2021","unstructured":"Joseph DB, Henry GH, Malewska A, Reese JC, Mauck RJ, Gahan JC, et al. Single-cell analysis of mouse and human prostate reveals novel fibroblasts with specialized distribution and microenvironment interactions. J Pathol. 2021;255(2):141\u201354.","journal-title":"J Pathol"},{"issue":"6","key":"16232_CR66","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.urolonc.2009.11.013","volume":"29","author":"C Boran","year":"2011","unstructured":"Boran C, Kandirali E, Yilmaz F, Serin E, Akyol M. Reliability of the 34\u03b2E12, keratin 5\/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma. Urologic Oncology: Seminars Original Investigations. 2011;29(6):614\u201323.","journal-title":"Urologic Oncology: Seminars Original Investigations"},{"issue":"46","key":"16232_CR67","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1038\/s41388-023-02859-4","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Giovannini S, Wang T, Fang J, Li P, Shao C, et al. p63: a crucial player in epithelial stemness regulation. Oncogene. 2023;42(46):3371\u201384.","journal-title":"Oncogene"},{"issue":"1","key":"16232_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/10668969241241640","volume":"33","author":"SK Potterveld","year":"2025","unstructured":"Potterveld SK, Williamson SR, Al-Obaidy KI, Akgul M, Chan E, Giannico GA, et al. GATA3 Expression in Prostatic Adenosquamous Carcinoma: A Potential Diagnostic Pitfall. Int J Surg Pathol. 2025;33(1):85\u201391.","journal-title":"Int J Surg Pathol"},{"key":"16232_CR69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.humpath.2018.05.014","volume":"79","author":"Z Xin","year":"2018","unstructured":"Xin Z, Zhang Y, Jiang Z, Zhao L, Fan L, Wang Y, et al. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate. Hum Pathol. 2018;79:151\u20139.","journal-title":"Hum Pathol"},{"issue":"10","key":"16232_CR70","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1007\/s11010-025-05318-8","volume":"480","author":"P Salu","year":"2025","unstructured":"Salu P, Reindl KM. Agr2 in cancer and beyond: unraveling its role during protein synthesis, ER stress, and as a predictive biomarker. Mol Cell Biochem. 2025;480(10):5205\u201319.","journal-title":"Mol Cell Biochem"},{"issue":"51","key":"16232_CR71","doi-asserted-by":"publisher","first-page":"20611","DOI":"10.1073\/pnas.1315729110","volume":"110","author":"YC Peng","year":"2013","unstructured":"Peng YC, Levine CM, Zahid S, Wilson EL, Joyner AL. Sonic hedgehog signals to multiple prostate stromal stem cells that replenish distinct stromal subtypes during regeneration. Proc Natl Acad Sci U S A. 2013;110(51):20611\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"16232_CR72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13072-024-00529-7","volume":"17","author":"R Sultanov","year":"2024","unstructured":"Sultanov R, Mulyukina A, Zubkova O, Fedoseeva A, Bogomazova A, Klimina K, et al. TP63\u2013TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer. Epigenetics Chromatin. 2024;17(1):6.","journal-title":"Epigenetics Chromatin"},{"issue":"9","key":"16232_CR73","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","volume":"125","author":"F Ahmad","year":"2021","unstructured":"Ahmad F, Cherukuri MK, Choyke PL. Metabolic reprogramming in prostate cancer. Br J Cancer. 2021;125(9):1185\u201396.","journal-title":"Br J Cancer"},{"issue":"1","key":"16232_CR74","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12935-025-03838-3","volume":"25","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Wang Y, Liu J, Sun K, Horie S, Bing Z, et al. Pericytes in castration-resistant prostate cancer associated with disease progression and immunotherapy response: insights from single-cell analysis. Cancer Cell Int. 2025;25(1):200.","journal-title":"Cancer Cell Int"},{"key":"16232_CR75","doi-asserted-by":"crossref","unstructured":"Krossa S, Andersen MK, Midtbust E, Wess M, Kiviaho A, Sharma A et al. Deep phenotyping of the prostate tumor microenvironment reveals molecular stratifiers of relapse linked to inflammatory chemokine expression and aberrant metabolism. bioRxiv. 2024:2024.05.13.593822.","DOI":"10.1101\/2024.05.13.593822"},{"issue":"1","key":"16232_CR76","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12885-025-14212-x","volume":"25","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Wang Y, Liu J, Sun K, Liu B, Hou Q. Single-cell sequencing unveils the transcriptomic landscape of castration-resistant prostate cancer-associated fibroblasts and their association with prognosis and immunotherapy response. BMC Cancer. 2025;25(1):813.","journal-title":"BMC Cancer"},{"issue":"1","key":"16232_CR77","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz T, Mei S, Sarkar H, Kfoury Y, Wu S, Verhoeven BM, et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun. 2023;14(1):663.","journal-title":"Nat Commun"},{"issue":"7091","key":"16232_CR78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature04733","volume":"441","author":"LA Boyer","year":"2006","unstructured":"Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441(7091):349\u201353.","journal-title":"Nature"},{"issue":"1","key":"16232_CR79","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13059-020-02024-0","volume":"21","author":"M Nishana","year":"2020","unstructured":"Nishana M, Ha C, Rodriguez-Hernaez J, Ranjbaran A, Chio E, Nora EP, et al. Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation. Genome Biol. 2020;21(1):108.","journal-title":"Genome Biol"},{"issue":"20","key":"16232_CR80","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1128\/MCB.00567-14","volume":"34","author":"M Xu","year":"2014","unstructured":"Xu M, Zhao GN, Lv X, Liu G, Wang LY, Hao DL, et al. CTCF controls HOXA cluster silencing and mediates PRC2-repressive higher-order chromatin structure in NT2\/D1 cells. Mol Cell Biol. 2014;34(20):3867\u201379.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"16232_CR81","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1128\/MCB.23.12.4056-4065.2003","volume":"23","author":"WG Zhu","year":"2003","unstructured":"Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, et al. Methylation of adjacent CpG sites affects Sp1\/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol. 2003;23(12):4056\u201365.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"16232_CR82","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/mend.14.5.0461","volume":"14","author":"S Lu","year":"2000","unstructured":"Lu S, Jenster G, Epner DE. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. Mol Endocrinol. 2000;14(5):753\u201360.","journal-title":"Mol Endocrinol"},{"issue":"10","key":"16232_CR83","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.celrep.2017.05.049","volume":"19","author":"A Urbanucci","year":"2017","unstructured":"Urbanucci A, Barfeld SJ, Kyt\u00f6l\u00e4 V, Itkonen HM, Coleman IM, Vod\u00e1k D, et al. Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer. Cell Rep. 2017;19(10):2045\u201359.","journal-title":"Cell Rep"},{"key":"16232_CR84","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gene.2017.07.077","volume":"629","author":"J He","year":"2017","unstructured":"He J, Huang Y, Liu Z, Zhao R, Liu Q, Wei L, et al. Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma. Gene. 2017;629:29\u201334.","journal-title":"Gene"},{"issue":"4","key":"16232_CR85","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.18632\/oncotarget.1697","volume":"5","author":"EA Hoivik","year":"2014","unstructured":"Hoivik EA, Kusonmano K, Halle MK, Berg A, Wik E, Werner HM, et al. Hypomethylation of the CTCFL\/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. Oncotarget. 2014;5(4):1052\u201361.","journal-title":"Oncotarget"},{"key":"16232_CR86","unstructured":"Available from: https:\/\/raw.githack.com\/bioFAM\/MOFA2_tutorials\/master\/R_tutorials\/CLL.html."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16232-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16232-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16232-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:02:59Z","timestamp":1786510979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16232-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16232"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16232-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients delivered a written informed consent, and the study was approved by the Regional Committee for Medical Research Ethics Central Norway (2017\/576), which follows EU and Norwegian ethical regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"967"}}